Literature DB >> 16449337

Functional characterization of the natural human glucocorticoid receptor (hGR) mutants hGRalphaR477H and hGRalphaG679S associated with generalized glucocorticoid resistance.

Evangelia Charmandari1, Tomoshige Kino, Takamasa Ichijo, Keith Zachman, Anton Alatsatianos, George P Chrousos.   

Abstract

BACKGROUND: Glucocorticoid resistance is often a result of mutations in the human glucocorticoid receptor alpha (hGRalpha) gene, which impair one or more of hGRalpha's functions. We investigated the molecular mechanisms through which two previously described mutant receptors, hGRalphaR477H and hGRalphaG679S, with amino acid substitutions in the DNA- and ligand-binding domains, respectively, affect glucocorticoid signal transduction. METHODS AND
RESULTS: In transient transfection assays, hGRalphaR477H displayed no transcriptional activity, whereas hGRalphaG679S showed a 55% reduction in its ability to stimulate the transcription of the glucocorticoid-responsive mouse mammary tumor virus promoter in response to dexamethasone compared with the wild-type hGRalpha. Neither hGRalphaR477H nor hGRalphaG679S exerted a dominant negative effect upon the wild-type receptor. Dexamethasone binding assays showed that hGRalphaR477H preserved normal affinity for the ligand, whereas hGRalphaG679S displayed a 2-fold reduction compared with hGRalpha. Nuclear translocation studies confirmed predominantly cytoplasmic localization of the mutant receptors in the absence of ligand. Exposure to dexamethasone resulted in slower translocation of hGRalphaR477H (25 min) and hGRalphaG679S (30 min) into the nucleus than the wild-type hGRalpha (12 min). In chromatin immunoprecipitation assays in cells stably transfected with the mouse mammary tumor virus promoter, hGRalphaR477H did not bind to glucocorticoid-response elements, whereas hGRalphaG679S preserved its ability to bind to glucocorticoid-response elements. Finally, in glutathione-S-transferase pull-down assays, hGRalphaG679S interacted with the glucocorticoid receptor-interacting protein 1 coactivator in vitro only through its activation function (AF)-1, unlike the hGRalphaR477H and hGRalpha, which interacted with the glucocorticoid receptor-interacting protein 1 through both their AF-1 and AF-2.
CONCLUSIONS: The natural mutants hGRalphaR477H and hGRalphaG679S cause generalized glucocorticoid resistance by affecting different functions of the glucocorticoid receptor, which span the cascade of the hGR signaling system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16449337     DOI: 10.1210/jc.2005-1893

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

Review 1.  Chrousos syndrome: a seminal report, a phylogenetic enigma and the clinical implications of glucocorticoid signalling changes.

Authors:  Evangelia Charmandari; Tomoshige Kino
Journal:  Eur J Clin Invest       Date:  2010-08-19       Impact factor: 4.686

Review 2.  Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder.

Authors:  Evangelia Charmandari; Tomoshige Kino; Takamasa Ichijo; George P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  2008-03-04       Impact factor: 5.958

Review 3.  Glucocorticoid sensitivity in health and disease.

Authors:  Rogier A Quax; Laura Manenschijn; Jan W Koper; Johanna M Hazes; Steven W J Lamberts; Elisabeth F C van Rossum; Richard A Feelders
Journal:  Nat Rev Endocrinol       Date:  2013-10-01       Impact factor: 43.330

4.  A novel point mutation in the DNA-binding domain (DBD) of the human glucocorticoid receptor causes primary generalized glucocorticoid resistance by disrupting the hydrophobic structure of its DBD.

Authors:  Michael L Roberts; Tomoshige Kino; Nicolas C Nicolaides; Darrell E Hurt; Eleni Katsantoni; Amalia Sertedaki; Filadelfia Komianou; Korina Kassiou; George P Chrousos; Evangelia Charmandari
Journal:  J Clin Endocrinol Metab       Date:  2013-02-20       Impact factor: 5.958

5.  A novel point mutation of the human glucocorticoid receptor gene causes primary generalized glucocorticoid resistance through impaired interaction with the LXXLL motif of the p160 coactivators: dissociation of the transactivating and transreppressive activities.

Authors:  Nicolas C Nicolaides; Michael L Roberts; Tomoshige Kino; Geoffrey Braatvedt; Darrell E Hurt; Eleni Katsantoni; Amalia Sertedaki; George P Chrousos; Evangelia Charmandari
Journal:  J Clin Endocrinol Metab       Date:  2014-01-31       Impact factor: 5.958

6.  A novel point mutation in the amino terminal domain of the human glucocorticoid receptor (hGR) gene enhancing hGR-mediated gene expression.

Authors:  Evangelia Charmandari; Takamasa Ichijo; William Jubiz; Smita Baid; Keith Zachman; George P Chrousos; Tomoshige Kino
Journal:  J Clin Endocrinol Metab       Date:  2008-09-30       Impact factor: 5.958

7.  Structural Analysis on the Pathologic Mutant Glucocorticoid Receptor Ligand-Binding Domains.

Authors:  Darrell E Hurt; Shigeru Suzuki; Takafumi Mayama; Evangelia Charmandari; Tomoshige Kino
Journal:  Mol Endocrinol       Date:  2016-01-08

Review 8.  The human glucocorticoid receptor: molecular basis of biologic function.

Authors:  Nicolas C Nicolaides; Zoi Galata; Tomoshige Kino; George P Chrousos; Evangelia Charmandari
Journal:  Steroids       Date:  2009-10-07       Impact factor: 2.668

Review 9.  Primary generalized familial and sporadic glucocorticoid resistance (Chrousos syndrome) and hypersensitivity.

Authors:  Evangelia Charmandari; Tomoshige Kino; George P Chrousos
Journal:  Endocr Dev       Date:  2013-02-01

10.  Human glucocorticoid receptor alpha gene (NR3C1) pharmacogenomics: gene resequencing and functional genomics.

Authors:  Nifang Niu; Venkatraman Manickam; Krishna R Kalari; Irene Moon; Linda L Pelleymounter; Bruce W Eckloff; Eric D Wieben; Daniel J Schaid; Liewei Wang
Journal:  J Clin Endocrinol Metab       Date:  2009-05-12       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.